XENE FY 2021 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M-42.7% YoY

Gross Profit

$18M100.0% margin

Operating Income

-$79M-428.4% margin

Net Income

-$79M-427.8% margin

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$72M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$572M

Total Liabilities

$22M

Stockholders' Equity

$550M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$32M	-42.7%
Gross Profit	$18M	$32M	-42.7%
Operating Income	-$79M	-$31M	-152.4%
Net Income	-$79M	-$29M	-173.5%